Significant overall survival improvement in proliferative subtype ovarian cancer patients receiving bevacizumab

Journal of Clinical Oncology, pp. 5520-5520, 2018.

Cited by: 2|Views27

Code:

Data:

Get fulltext within 24h
Bibtex
Your rating :
0

 

Tags
Comments